FDA/EMA current thinking on total evidence for development of biosimilars
Kamali Chance
Strategic partnership for biologics RD
Jianguo Yang
Biosimilars: Accelerating early clinical development
Raymond A Huml
Strategy for the global development of biosimilars: Putting it all together
Oxana Iliach
Clinical development of biosimilars for Western markets: Planning for success
Charu Manaktala
Biosimilars in treatment of multiple sclerosis
Hossein Pakdaman
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report